Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease

被引：80
|
作者：
Tan, Xin [1 ]
Chen, Huaisheng [2 ]
Zhang, Min [3 ,4 ]
Zhao, Ying [5 ]
Jiang, Yichun [2 ]
Liu, Xueyan [2 ]
Huang, Wei [3 ,4 ]
Ma, Yingfei [1 ]
机构：
[1] Chinese Acad Sci, Shenzhen Key Lab Synthet Genom, Guangdong Prov Key Lab Synthet Genom,Shenzhen Ins, CAS Key Lab Quantitat Engn Biol,Shenzhen Inst Syn, Shenzhen, Peoples R China
[2] South Univ Sci & Technol, Affiliated Hosp 1, Jinan Univ, Dept Crit Care Med,Shenzhen Peoples Hosp,Second C, Shenzhen, Peoples R China
[3] Shenzhen Peoples Hosp, Shenzhen Inst Resp Dis, Shenzhen, Peoples R China
[4] Southern Univ Sci & Technol, Affiliated Hosp 1, Jinan Univ,Shenzhen Peoples Hosp,Second Clin Med, Bacteriol & Antibacterial Resistance Surveillance, Shenzhen, Peoples R China
[5] Southern Univ Sci & Technol, Affiliated Hosp 1, Jinan Univ, Dept Geriatr,Shenzhen Peoples Hosp,Second Clin Co, Shenzhen, Peoples R China
来源：
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2021年 / 11卷
关键词：
carbapenem-resistant Acinetobacter baumannii; lung infection; personalized phage therapy; phage; endotoxin;
D O I：
10.3389/fcimb.2021.631585
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Overuse of antibiotics in clinical medicine has contributed to the global spread of multidrug-resistant bacterial pathogens, including Acinetobacter baumannii. We present a case of an 88-year-old Chinese man who developed hospital-acquired pneumonia caused by carbapenem-resistant A. baumannii (CRAB). A personalized lytic pathogen-specific single-phage preparation was nebulized to the patient continuously for 16 days in combination with tigecycline and polymyxin E. The treatment was well tolerated and resulted in clearance of the pathogen and clinical improvement of the patient's lung function.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice
    Hua, Yunfen
    Luo, Tingting
    Yang, Yiqi
    Dong, Dong
    Wang, Rui
    Wang, Yanjun
    Xu, Mengsha
    Guo, Xiaokui
    Hu, Fupin
    He, Ping
    FRONTIERS IN MICROBIOLOGY, 2018, 8
  • [2] Antimicrobial photodynamic therapy against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii
    Mirian Marcolan De Mello
    Patrícia Pimentel De Barros
    Renata de Cassia Bernardes
    Silvio Rubens Alves
    Naiara Pires Ramanzini
    Lívia Mara Alves Figueiredo-Godoi
    Ana Carolina Chipoletti Prado
    Antonio Olavo Cardoso Jorge
    Juliana Campos Junqueira
    Lasers in Medical Science, 2019, 34 : 1755 - 1761
  • [3] Antimicrobial photodynamic therapy against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii
    De Mello, Mirian Marcolan
    De Barros, Patricia Pimentel
    Bernardes, Renata de Cassia
    Alves, Silvio Rubens
    Ramanzini, Naiara Pires
    Alves Figueiredo-Godoi, Livia Mara
    Chipoletti Prado, Ana Carolina
    Cardoso Jorge, Antonio Olavo
    Junqueira, Juliana Campos
    LASERS IN MEDICAL SCIENCE, 2019, 34 (09) : 1755 - 1761
  • [4] Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Infection
    Choi, Joonhyeok
    Jang, Ahjin
    Yoon, Young Kyung
    Kim, Yangmee
    PHARMACEUTICS, 2021, 13 (11)
  • [5] Characterization and efficacy against carbapenem-resistant Acinetobacter baumannii of a novel Friunavirus phage from sewage
    Wang, Zhitao
    Yang, Xue
    Wang, Hui
    Wang, Shuxian
    Fang, Ren
    Li, Xiaotian
    Xing, Jiayin
    Wu, Qianqian
    Li, Zhaoli
    Song, Ningning
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [6] In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience
    Quirino, Angela
    Cicino, Claudia
    Scaglione, Vincenzo
    Marascio, Nadia
    Serapide, Francesca
    Scarlata, Giuseppe Guido Maria
    Lionello, Rosaria
    Divenuto, Francesca
    La Gamba, Valentina
    Pavia, Grazia
    Russo, Alessandro
    Torti, Carlo
    Matera, Giovanni
    Trecarichi, Enrico Maria
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15 (01)
  • [7] Antibacterial activity of silver nanoparticles against carbapenem-resistant Acinetobacter baumannii clinical isolates
    Shah, Asad Ali
    Ahmad, Ijaz
    Shafique, Muhammad
    Siddique, Abu Baker
    Aslam, Bilal
    Qamar, Muhammad Usman
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 35 (01) : 203 - 208
  • [8] Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection
    Du, Ning
    You, Dan
    Tenzing, Dava
    Qu, Dongxiang
    Meng, Jun
    Wang, Yihui
    He, Juan
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 3617 - 3621
  • [9] Synergy of lytic phage pB23 and meropenem combination against carbapenem-resistant Acinetobacter baumannii
    Luo, Jun
    Liu, Min
    Ai, Wen
    Zheng, Xiaoling
    Liu, Shaowei
    Huang, Kuo
    Zhang, Changlin
    Li, Qianyuan
    Luo, Chunhua
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (06)
  • [10] Intratracheal Phage Therapy Against Acinetobacter Baumannii Lung Infection in Mice
    Wienhold, S.
    Brack, M. C.
    Nouailles, G.
    Suttorp, N. W.
    Seitz, C.
    Ross, A.
    Ziehr, H.
    Gurtner, C.
    Kershaw, O.
    Dietert, K.
    Gruber, A. D.
    Rohde, M.
    Rohde, C.
    Witzenrath, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345